Homology Medicines, Inc. (0T6G.L)

USD 3.22

(-5.26%)

Revenue Summary of Homology Medicines, Inc.

  • Homology Medicines, Inc.'s latest annual revenue in 2023 was -6.65 Million USD , down -307.33% from previous year.
  • Homology Medicines, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Homology Medicines, Inc. reported a annual revenue of 3.2 Million USD in annual revenue 2022, down -90.56% from previous year.
  • Homology Medicines, Inc. reported a annual revenue of 33.97 Million USD in annual revenue 2021, up 1157.25% from previous year.
  • Homology Medicines, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Homology Medicines, Inc. reported a quarterly revenue of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Revenue Chart of Homology Medicines, Inc. (2023 - 2016)

Historical Annual Revenue of Homology Medicines, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 -6.65 Million USD -307.33%
2022 3.2 Million USD -90.56%
2021 33.97 Million USD 1157.25%
2020 2.7 Million USD 62.18%
2019 1.66 Million USD -68.7%
2018 5.32 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Revenue Comparison of Homology Medicines, Inc.

Name Revenue Revenue Difference
Editas Medicine, Inc. 78.12 Million USD 108.513%
Dynavax Technologies Corporation 232.28 Million USD 102.863%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 101.095%
Perrigo Company plc 4.65 Billion USD 100.143%
Illumina, Inc. 4.5 Billion USD 100.148%
Thermo Fisher Scientific Inc. 42.85 Billion USD 100.016%
Iovance Biotherapeutics, Inc. 1.18 Million USD 659.378%
Walgreens Boots Alliance, Inc. 147.65 Billion USD 100.005%
IQVIA Holdings Inc. 14.98 Billion USD 100.044%
Heron Therapeutics, Inc. 127.04 Million USD 105.235%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 100.051%
Unity Biotechnology, Inc. - USD Infinity%
Waters Corporation 2.95 Billion USD 100.225%
Biogen Inc. 9.83 Billion USD 100.068%
Sangamo Therapeutics, Inc. 176.23 Million USD 103.774%
Evolus, Inc. 202.08 Million USD 103.291%
Adicet Bio, Inc. - USD Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 131.72%
bluebird bio, Inc. 29.49 Million USD 122.548%
Esperion Therapeutics, Inc. 116.33 Million USD 105.717%
FibroGen, Inc. 147.75 Million USD 104.501%
Agilent Technologies, Inc. 6.83 Billion USD 100.097%
Corbus Pharmaceuticals Holdings, Inc. - USD Infinity%
Geron Corporation 237 Thousand USD 2906.329%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 100.364%
Amicus Therapeutics, Inc. 399.35 Million USD 101.665%
Myriad Genetics, Inc. 678.4 Million USD 100.98%
Viking Therapeutics, Inc. - USD Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 118.335%
Zoetis Inc. 8.54 Billion USD 100.078%
Abeona Therapeutics Inc. 3.5 Million USD 290.029%
Mettler-Toledo International Inc. 3.78 Billion USD 100.176%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 100.275%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 100.067%
Kala Pharmaceuticals, Inc. - USD Infinity%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 100.844%
Atara Biotherapeutics, Inc. 8.57 Million USD 177.581%
Verastem, Inc. - USD Infinity%
Nektar Therapeutics 90.12 Million USD 107.38%
Axsome Therapeutics, Inc. 270.6 Million USD 102.458%
Aclaris Therapeutics, Inc. 31.24 Million USD 121.284%
Sarepta Therapeutics, Inc. 1.24 Billion USD 100.535%
OPKO Health, Inc. 863.49 Million USD 100.77%
Exelixis, Inc. 1.83 Billion USD 100.363%
Neurocrine Biosciences, Inc. 1.88 Billion USD 100.352%
Corcept Therapeutics Incorporated 482.37 Million USD 101.379%
Anavex Life Sciences Corp. - USD Infinity%
uniQure N.V. 15.84 Million USD 141.981%
Imunon, Inc. - USD Infinity%
Blueprint Medicines Corporation 249.38 Million USD 102.667%
Insmed Incorporated 305.2 Million USD 102.179%
Halozyme Therapeutics, Inc. 829.25 Million USD 100.802%
Agios Pharmaceuticals, Inc. 26.82 Million USD 124.796%
TG Therapeutics, Inc. 233.66 Million USD 102.846%
Incyte Corporation 3.69 Billion USD 100.18%
Emergent BioSolutions Inc. 1.04 Billion USD 100.634%